These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2428463)

  • 21. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
    Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
    Pant KD; Shochat D; Nelson MO; Goldenberg DM
    Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human tumor-associated antigens identified by monoclonal antibodies.
    Hellström KE; Hellström I; Brown JP
    Springer Semin Immunopathol; 1982; 5(2):127-46. PubMed ID: 6183764
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 28. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of CA 19-9 in gastric and colorectal carcinoma.
    Safi F; Bittner R; Roscher R; Kübel R; Beger HG
    Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers.
    Sugano K; Ohkura H; Maruyama T; Watanabe M; Hirohashi S; Shimosato Y; Kodaira S; Abe O
    Jpn J Cancer Res; 1988 May; 79(5):618-25. PubMed ID: 3136114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New monoclonal antibodies against colon cancer-associated antigens.
    Drewinko B; Yang LY; Chan J; Trujillo JM
    Cancer Res; 1986 Oct; 46(10):5137-43. PubMed ID: 2428473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
    Fink LM; Clarke SM
    Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
    Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
    Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoembryonic antigen in cancer of the female reproductive system: sequential levels and effects of treatment.
    Khoo SK; Mackay EV
    Aust N Z J Obstet Gynaecol; 1973 Feb; 13(1):1-17. PubMed ID: 4514543
    [No Abstract]   [Full Text] [Related]  

  • 36. Serial levels of CA 19-9 and CEA in colonic cancer.
    Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
    J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
    Klug TL; Sattler MA; Colcher D; Schlom J
    Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress in the immunological monitoring of carcinomas using monoclonal antibodies.
    Papsidero LD
    Semin Surg Oncol; 1985; 1(4):171-81. PubMed ID: 2418482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
    Wagener C; Petzold P; Köhler W; Totović V
    Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
    Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
    Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.